CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 89 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,214,218 | +368714.6% | 552,166 | +122.2% | 0.01% | +233.3% |
| Q1 2023 | $5,752 | -50.2% | 248,454 | -43.6% | 0.00% | -50.0% |
| Q4 2022 | $11,547 | -99.9% | 440,738 | +10.5% | 0.01% | +20.0% |
| Q3 2022 | $7,844,000 | -62.2% | 398,969 | -66.3% | 0.01% | -61.5% |
| Q2 2022 | $20,730,000 | +71.9% | 1,185,233 | +60.8% | 0.01% | +116.7% |
| Q1 2022 | $12,060,000 | +111.0% | 737,139 | +110.3% | 0.01% | +100.0% |
| Q4 2021 | $5,716,000 | -32.6% | 350,444 | -47.3% | 0.00% | -40.0% |
| Q3 2021 | $8,479,000 | +92.7% | 664,476 | +113.3% | 0.01% | +66.7% |
| Q2 2021 | $4,399,000 | -30.9% | 311,561 | -23.9% | 0.00% | -40.0% |
| Q1 2021 | $6,363,000 | +299.9% | 409,487 | +308.1% | 0.01% | +400.0% |
| Q4 2020 | $1,591,000 | – | 100,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |